Clinical Research Directory
Browse clinical research sites, groups, and studies.
Asiaticoside for Treating Overweight/Obesity
Sponsor: Shanghai Zhongshan Hospital
Summary
Centella asiatica is a traditional herbal medicine widely used in China and Southeast Asia for treating various conditions. Preclinical studies have shown that madecassic acid glycosides, including asiaticoside and madecassoside, can significantly reduce body weight gain, adipose tissue mass, and serum triglyceride levels in high-fat diet-induced obese mice. These compounds also improve hepatic steatosis and insulin resistance. This exploratory, interventional study aims to evaluate the clinical efficacy of orally administered asiaticoside tablets in adults with overweight or obesity.
Official title: A Clinical Efficacy Study of Asiaticoside for Treating Overweight/Obesity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-12-01
Completion Date
2026-11
Last Updated
2025-12-24
Healthy Volunteers
No
Conditions
Interventions
Asiaticoside tablets
Asiaticoside tablets 60mg tid for 12 weeks
Locations (1)
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China